• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Screening of dysfibrinogenaemia using the fibrinogen function versus antigen concentration ratio.

作者信息

Krammer B, Anders O, Nagel H R, Burstein C, Steiner M

机构信息

University of Rostock, Faculty of Medicine, Department of Internal Medicine, Germany.

出版信息

Thromb Res. 1994 Dec 15;76(6):577-9. doi: 10.1016/0049-3848(94)90287-9.

DOI:10.1016/0049-3848(94)90287-9
PMID:7900105
Abstract

The diagnosis of inherited and acquired dysfibrinogenaemia is usually suspected in patients with otherwise unexplained prolonged thrombin time or other tests with thrombin-like enzymes (1). Confirmation of the diagnosis requires discordant results from the investigation of functional fibrinogen and its antigen concentration. However, the issue of the difference between the two results required to confirm dysfibrinogenaemia has rarely been addressed. A difference of at least 0.5 g/l between functional fibrinogen using the method of Clauss and heat precipitation method according to Schulz has been suggested as a prerequisite (1). In the case of acquired dysfibrinogenaemia with an underlying liver disease the discordance should reach at least 1.0 g/l (2). Rodgers and Garr (3) suggested to establish a ratio between fibrinogen function and antigen concentration. In that study plasma from healthy blood donors was investigated using the Clauss method and radial immunodiffusion. We applied this approach to randomly selected patients at the time of admission to a University Hospital Department. Since fibrinogen is one of the major acute phase proteins, the determination of the C-reactive protein (CRP) was included for comparison.

摘要

相似文献

1
Screening of dysfibrinogenaemia using the fibrinogen function versus antigen concentration ratio.
Thromb Res. 1994 Dec 15;76(6):577-9. doi: 10.1016/0049-3848(94)90287-9.
2
Potential misdiagnosis of dysfibrinogenaemia: Data from multicentre studies amongst UK NEQAS and PRO-RBDD project laboratories.异常纤维蛋白原血症的潜在误诊:来自英国国家外部质量评估计划(NEQAS)和PRO-RBDD项目实验室的多中心研究数据。
Int J Lab Hematol. 2017 Dec;39(6):653-662. doi: 10.1111/ijlh.12721. Epub 2017 Aug 2.
3
Comparison of the fibrinogen Clauss assay and the fibrinogen PT derived method in patients with dysfibrinogenemia.在纤维蛋白原异常血症患者中比较 Clauss 法纤维蛋白原测定和基于凝血酶原时间的纤维蛋白原检测方法。
Thromb Res. 2010 Dec;126(6):e428-33. doi: 10.1016/j.thromres.2010.09.004. Epub 2010 Oct 13.
4
Investigation of acquired dysfibrinogenaemia in adult patients with sepsis using fibrinogen function vs. concentration ratios: a cross-sectional study.利用纤维蛋白原功能与浓度比值对成年脓毒症患者获得性异常纤维蛋白原血症的研究:一项横断面研究。
Front Med (Lausanne). 2023 Dec 13;10:1294301. doi: 10.3389/fmed.2023.1294301. eCollection 2023.
5
Screening method for congenital dysfibrinogenemia using clot waveform analysis with the Clauss method.应用 Clauss 法的血栓波形分析对先天性纤维蛋白原异常血症进行筛查的方法。
Int J Lab Hematol. 2021 Apr;43(2):281-289. doi: 10.1111/ijlh.13358. Epub 2020 Oct 8.
6
Combined use of Clauss and prothrombin time-derived methods for determining fibrinogen concentrations: Screening for congenital dysfibrinogenemia.联合使用Clauss法和凝血酶原时间衍生法测定纤维蛋白原浓度:先天性异常纤维蛋白原血症的筛查
J Clin Lab Anal. 2018 May;32(4):e22322. doi: 10.1002/jcla.22322. Epub 2017 Sep 18.
7
Modified approach to fibrinogen replacement in the setting of dysfibrinogenaemia.异常纤维蛋白原血症时纤维蛋白原替代治疗方法的改良。
J Clin Pathol. 2019 Feb;72(2):177-180. doi: 10.1136/jclinpath-2018-205438. Epub 2018 Nov 21.
8
Fibrinogen Marseille. A new case of congenital dysfibrinogenaemia.马赛纤维蛋白原。先天性异常纤维蛋白原血症一例新病例。
Haemostasis. 1980;9(4):214-25. doi: 10.1159/000214360.
9
Congenital dysfibrinogenaemia assessed by whole blood thromboelastography.全血血栓弹力描记术评估先天性纤维蛋白原血症。
Int J Lab Hematol. 2018 Aug;40(4):459-465. doi: 10.1111/ijlh.12827. Epub 2018 Apr 30.
10
Congenital dysfibrinogenaemia presented with preterm premature rupture of the membranes and vaginal bleeding.先天性纤维蛋白原血症表现为早产胎膜早破和阴道出血。
BMJ Case Rep. 2020 Sep 18;13(9):e235961. doi: 10.1136/bcr-2020-235961.

引用本文的文献

1
Clinical Application of Clot Waveform Analysis.血栓波形分析的临床应用
Clin Appl Thromb Hemost. 2025 Jan-Dec;31:10760296251331606. doi: 10.1177/10760296251331606. Epub 2025 Apr 1.
2
Investigation of acquired dysfibrinogenaemia in adult patients with sepsis using fibrinogen function vs. concentration ratios: a cross-sectional study.利用纤维蛋白原功能与浓度比值对成年脓毒症患者获得性异常纤维蛋白原血症的研究:一项横断面研究。
Front Med (Lausanne). 2023 Dec 13;10:1294301. doi: 10.3389/fmed.2023.1294301. eCollection 2023.
3
Development and validation of a novel qualitative test for plasma fibrinogen utilizing clot waveform analysis.
利用血栓波分析开发和验证一种新型的血浆纤维蛋白原定性检测方法。
Sci Rep. 2022 Jan 21;12(1):434. doi: 10.1038/s41598-021-04464-5.
4
Congenital Afibrinogenemia and Hypofibrinogenemia: Laboratory and Genetic Testing in Rare Bleeding Disorders with Life-Threatening Clinical Manifestations and Challenging Management.先天性无纤维蛋白原血症和低纤维蛋白原血症:危及生命的临床表现和具有挑战性管理的罕见出血性疾病的实验室和基因检测
Diagnostics (Basel). 2021 Nov 19;11(11):2140. doi: 10.3390/diagnostics11112140.
5
[Analysis of gene mutation spectrum and pharmacokinetics of fibrinogen infusion in 146 cases of congenital fibrinogen disorders].146例先天性纤维蛋白原异常患者纤维蛋白原输注的基因突变谱及药代动力学分析
Zhonghua Xue Ye Xue Za Zhi. 2021 Jul 14;42(7):555-562. doi: 10.3760/cma.j.issn.0253-2727.2021.07.005.
6
Whole Blood Thromboelastometry by ROTEM and Thrombin Generation by Genesia According to the Genotype and Clinical Phenotype in Congenital Fibrinogen Disorders.根据先天性纤维蛋白原紊乱的基因型和临床表型,采用 ROTEM 的全血血栓弹力描记术和 Genesia 的凝血酶生成。
Int J Mol Sci. 2021 Feb 25;22(5):2286. doi: 10.3390/ijms22052286.
7
Congenital fibrinogen disorders with repeated thrombosis.先天性纤维蛋白原异常伴反复血栓形成。
J Thromb Thrombolysis. 2020 Feb;49(2):312-315. doi: 10.1007/s11239-019-01958-y.
8
Clinical Consequences and Molecular Bases of Low Fibrinogen Levels.低纤维蛋白原水平的临床后果和分子基础。
Int J Mol Sci. 2018 Jan 8;19(1):192. doi: 10.3390/ijms19010192.
9
Natural history of patients with congenital dysfibrinogenemia.先天性纤维蛋白原异常血症患者的自然病史。
Blood. 2015 Jan 15;125(3):553-61. doi: 10.1182/blood-2014-06-582866. Epub 2014 Oct 15.